Business Context and Reporting Period
BlueLinx Holdings Inc. distributes structural and specialty building products through U.S. distribution centers. The supplied filing is a Form 10-Q for the quarter ended June 27, 2020, not 2019 Q2 as stated in the request metadata. Fiscal 2020 is a 53-week year. Financial statements are unaudited.
Financial Performance
Amounts below are in millions, except per-share data and percentages.
| Metric | Q2 2020 | Q2 2019 | First half 2020 | First half 2019 |
|---|---|---|---|---|
| Net sales | $698.8 | $706.4 | $1,360.8 | $1,345.1 |
| Gross profit / margin | $100.8 / 14.4% | $94.2 / 13.3% | $194.0 / 14.3% | $180.2 / 13.4% |
| Operating income | $22.1 | $22.3 | $30.4 | $26.6 |
| Interest expense, net | $11.5 | $13.7 | $25.9 | $27.1 |
| Net income (loss) | $6.7 | $6.3 | $5.9 | $(0.4) |
| Diluted EPS | $0.71 | $0.67 | $0.63 | $(0.04) |
| Operating cash flow | Not presented quarterly | $12.9 | $(53.0) |
Q2 sales declined 1.1%; the company attributed the decrease mainly to a discontinued siding program, partly offset by structural-product volume and commodity-price inflation. Q2 structural sales rose to $249.6 million from $224.5 million, while specialty sales fell to $449.2 million from $481.9 million. Gross profit improved in both categories, with margins rising to 9.3% for structural and 17.3% for specialty products.
Q2 operating income was nearly unchanged despite higher gross profit, in part because the prior-year quarter included a $9.8 million gain on property sales and 2020 had no comparable sale. First-half net income included a $3.9 million discrete tax benefit related to the CARES Act. The company reported cash of $11.5 million at June 27, 2020, versus $11.6 million at fiscal year-end. First-half investing cash use was $1.7 million and financing cash use was $11.4 million.
Debt, Liquidity and Balance Sheet
At June 27, 2020, revolving-facility borrowings were $322.2 million, with $138.1 million of excess availability and a 2.6% weighted-average rate. Term-loan borrowings were $68.8 million at an 8.0% rate. The company reported compliance with both facilities’ covenants. Finance lease obligations were $272.6 million; total finance lease liabilities increased from $198.0 million at December 28, 2019. Total liabilities were $1,017.4 million, exceeding total assets of $999.1 million, and stockholders’ deficit was $18.2 million.
First-half operating cash flow improved by $65.9 million year over year, turning positive from a use of cash. The company cited net income and lower working capital use; receivables nevertheless absorbed $71.8 million, partly offset by a $31.8 million inventory reduction and higher accounts payable. Operating working capital was $431.2 million, up $13.3 million from year-end. Management stated that available cash, normal-course sales and revolving-facility availability were expected to fund routine needs for at least 12 months, assuming no prolonged significant pandemic impact.
Outlook, Commentary and Risks
- No numerical earnings or sales guidance was provided. Management said the pandemic’s effects in the second half of 2020 remained uncertain and dependent on its duration, reopening activity and demand.
- BlueLinx said Q2 pandemic effects were less severe than initially anticipated; its business remained designated essential, and it had not experienced significant supply-chain disruption. Housing starts were down 13% year over year for Q2, but monthly comparisons improved from a 23% decline in April to 2% in June.
- Management cited cost controls, hiring and spending limits, workforce furloughs and reductions, and tighter inventory oversight. It expected to maintain many cost-reduction actions long term.
- Commodity-price movements, housing and construction activity, customer creditworthiness, supply-chain conditions, and COVID-19 were identified as material uncertainties. The company also cited potential impairment risk and possible effects on sales, profitability, collections, credit availability and operations.
- NYSE notified the company that it failed a continued-listing standard because market capitalization and stockholders’ equity were below $50 million. The exchange accepted a compliance plan through January 1, 2022; the stock remained listed during the cure period, but delisting remained a risk if compliance was not restored.
- Real-estate financing transactions generated $78.3 million of proceeds in the first half, applied toward term-loan repayment, while increasing long-term finance lease obligations. The company completed transactions involving 14 warehouse properties in early 2020.
- Management reported effective disclosure controls. Routine legal matters were not expected to materially affect financial condition, results or cash flows. Two collective bargaining agreements were expected to be renegotiated later in 2020.
Most Important Facts to Verify
- Confirm the reporting period: the filing covers the quarter ended June 27, 2020, notwithstanding the request’s “2019 Q2” label.
- Assess whether gross-margin improvement and structural-product recovery persisted, and whether COVID-19 or housing-market changes affected subsequent results.
- Review liquidity and covenant headroom, including the $138.1 million revolving availability, the term loan’s leverage requirements and the company’s cash needs.
- Track total debt and lease commitments together: finance lease obligations rose materially as sale-leaseback financing funded term-loan repayments.
- Monitor progress toward NYSE listing compliance and the related risk to share liquidity and access to capital.
- Separate recurring performance from unusual items, particularly the CARES Act tax benefit and prior-year property-sale gain.